No Data
No Data
Cantor Fitzgerald Initiates TriSalus Life Sciences(TLSI.US) With Buy Rating, Announces Target Price $10
Cantor Fitzgerald Initiates Coverage On TriSalus Life Sciences With Overweight Rating, Announces Price Target of $10
Maxim Group Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Maintains Target Price $16
TriSalus Life Sciences: Strong Buy Recommendation Supported by Robust Financial Growth and Strategic Advancements
TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity
TriSalus Life Sciences Price Target Cut to $11.00/Share From $12.00 by Canaccord Genuity
Unlock the Full List